Shares of Sciclone Pharmaceuticals Rise to a New 52-Week High
Sciclone Pharmaceuticals (NASDAQ:SCLN) traded today at a new 52-week high of $14.22. Approximately 79,000 shares have changed hands today, as compared to an average 30-day volume of 824,000 shares.
SciClone Pharmaceuticals, Inc. is a global biopharmaceutical company that acquires, develops, and commercializes specialist-oriented drugs. The Company's products are for treating chronic and life-threatening diseases such as cancer, hepatitis B, hepatitis C, cystic fibrosis, and immune system disorders.
Sciclone Pharmaceuticals share prices have moved between a 52-week high of $14.22 and a 52-week low of $6.47 and are now trading 120% above that low price at $14.22 per share. In the last five trading sessions, the 50-day moving average (MA) has climbed 2.9% while the 200-day MA has risen 0.8%.
There is potential upside of 5.5% for shares of Sciclone Pharmaceuticals based on a current price of $14.22 and an average consensus analyst price target of $15.00. The stock should discover initial support at its 50-day moving average (MA) of $11.25 and subsequent support at its 200-day MA of $9.02.
SmarTrend recommended that subscribers consider buying shares of Sciclone Pharmaceuticals on November 9th, 2015 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $7.98. Since that recommendation, shares of Sciclone Pharmaceuticals have risen 77.4%. We continue to monitor SCLN for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.
Keywords: 52 week high/lows sciclone pharmaceuticals